6.4 Returning, Reusing & Re-Dispensing Prescription Medication

6.4 Returning, Reusing & Re-Dispensing Prescription Medication

[!NOTE] Core Legal Authorities: Return of prescription medication (N.J.A.C. 13:39-7.16, amended effective December 4, 2017), the long-term care exception referenced at N.J.A.C. 13:39-9.18(a)2, disposal of unwanted drugs (N.J.A.C. 13:39-7.17), outdated drugs or drugs marked "sample" (N.J.A.C. 13:39-7.18), the re-dispensing statute N.J.S.A. 45:14-57.1 (P.L. 2016, c.42, approved August 31, 2016), and federal DEA disposal rules at 21 CFR Part 1317.

"Returning or reusing drugs" is its own line item in the MPJE Competency Statements, and it is one of the few areas where New Jersey's rule is genuinely counterintuitive: the state permits accepting a return in circumstances where it flatly forbids reusing what was returned. Candidates who collapse those two questions into one get the item wrong.

---

The Two Questions Are Separate

         Medication comes back to the pharmacy
                          │
     ┌────────────────────┴────────────────────┐
     ▼                                         ▼
 Q1: MAY the pharmacist                 Q2: MAY it go back
     accept the return?                     into stock?
     Often yes.                             Usually NO.

Rule 1 — Correctly Dispensed Medication

N.J.A.C. 13:39-7.16(a): prescription medication correctly dispensed to a patient may be accepted for return by the pharmacist, but shall not be placed in stock for reuse or resale, except as provided in N.J.A.C. 13:39-9.18(a)2.

The permissive verb governs acceptance only. Once product has been dispensed to a patient and has left the pharmacy's exclusive control, its storage history is unverifiable — it may have sat in a hot car or a humid bathroom — so it cannot re-enter stock. Taking it back for safe disposal is a service the pharmacist may render; restocking it is not.

Rule 2 — Incorrectly Dispensed Medication

N.J.A.C. 13:39-7.16(b): prescription medication incorrectly dispensed to a patient shall be accepted for return by the pharmacist and shall not be placed back in stock for reuse or resale.

Note the shift from may to shall. Where the pharmacy made the error, accepting the return is mandatory, not discretionary — the patient cannot be left holding the wrong drug. The restocking prohibition is unchanged.

---

The Abandoned-Prescription Exception

The genuine exception in New Jersey law covers medication that was prepared but never reached the patient. N.J.A.C. 13:39-7.16(c) defines the trigger precisely: a prescription medication is considered abandoned when a prescription is prepared and made available for dispensing by the pharmacy but is not dispensed to the patient for whom it was prepared within two weeks.

Abandoned medication — and medication that a long-term care pharmacy did not dispense to a patient in a long-term care facility — may be placed back in stock for reuse or resale, provided all six of the following conditions are met:

[!WARNING] The one-year figure changed — and stale material still says six months. Before 2016 the rule capped re-dispensing at six months from original preparation. P.L. 2016, c.42 (Assembly Bill A3434, approved August 31, 2016), codified at N.J.S.A. 45:14-57.1, extended the outer limit to one year, and the Board conformed the rule effective December 4, 2017. If a study source says six months, it predates the amendment.

[!IMPORTANT] Condition 1 does the real work. "Exclusive control and custody of the pharmacy or the patient's long-term care facility at all times" is why a prescription a patient carried home and brought back can never qualify, no matter how sealed the bottle looks — the chain of custody broke the moment it left. It is also why condition 5 exists: once product sits in a repackaged container with no manufacturer lot number, the pharmacy cannot exclude it from a recall, so it must treat it as recalled.

---

Controlled Substances: A Separate Federal Overlay

Nothing in 13:39-7.16 authorizes a pharmacy to take back controlled substances from an ultimate user in the ordinary course. Under the federal disposal framework at 21 CFR Part 1317:

• A pharmacy may receive controlled substances from an ultimate user only if it has become a DEA-authorized collector, and then only through a compliant collection receptacle or mail-back program.
• Collection receptacle liners are not to be opened, inspected, or inventoried by pharmacy staff; the guide's inventory chapter covers the two-employee installation and sealing requirements.
• Product returned from pharmacy stock to a reverse distributor is a different transaction entirely: Schedule II transfers require a DEA Form 222 initiated by the reverse distributor, while Schedules III–V move on an invoice, with final destruction documented by the reverse distributor on DEA Form 41.

---

When It Cannot Be Reused: The Disposal Pathways

New Jersey also runs Project Medicine Drop, the Division of Consumer Affairs take-back program that places permanent collection boxes in law enforcement facilities and participating pharmacies. It is the appropriate referral when a patient asks what to do with leftover medication that the pharmacy cannot accept.

---

Practice Scenarios

Scenario 1 — The unopened bottle. A patient returns an unopened, sealed bottle of atorvastatin dispensed three days ago, explaining that her physician switched her to a different statin. She asks for a refund and notes the seal was never broken. Analysis: The pharmacist may accept the return under 13:39-7.16(a) but may not restock it. The bottle left the pharmacy's exclusive custody, and an intact seal proves nothing about the storage conditions in between. Refund policy is a business decision; restocking is a regulatory prohibition.

Scenario 2 — The wrong drug. A pharmacy dispenses metoprolol tartrate where the prescription specified metoprolol succinate, and the patient returns the next morning. Analysis: Under 13:39-7.16(b) the pharmacist shall accept the return — acceptance is mandatory where the pharmacy erred. The returned product still cannot go back into stock. The event is also a prescription error that must feed the pharmacy's CQI program under 13:39-1.9.

Scenario 3 — The will-call bin. A prescription for sertraline was filled and bagged on March 1 and is still in the will-call bin on March 20; the patient never came in and does not answer calls. Analysis: It became abandoned on March 15 — two weeks after being prepared and made available. Because it never left the pharmacy's exclusive control, it may be returned to stock if all six conditions of 13:39-7.16(c) are satisfied: it must not be commingled into a stock container with a different lot number or expiration date, the container must not be over-filled, it must be relabeled if it cannot go back to the original manufacturer's container, it must be used as soon as possible, and it cannot be dispensed later than one year from March 1, carrying the same use-by date it was originally given.

Scenario 4 — The recall notice. The same pharmacy holds several repackaged, relabeled quantities from abandoned prescriptions when the manufacturer announces a lot-specific recall. The held containers bear no manufacturer lot numbers. Analysis: Condition 5 resolves it: the pharmacist must assume the held product is included in the recall and proceed accordingly. Absence of a lot number is not a reason to exclude product from a recall; it is the reason to include it.